LAURUS LABS
Back to Cashflow Statement
|
LAURUS LABS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹10 Cr | ₹-41 Cr | ₹93 Cr | ₹-29 Cr | ₹27 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LAURUS LABS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹10 Cr |
| Mar2025 | ₹-41 Cr |
| Mar2024 | ₹93 Cr |
| Mar2023 | ₹-29 Cr |
| Mar2022 | ₹27 Cr |
How is Net Cash Inflow / Outflow of LAURUS LABS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹10 Cr | Positive | |
| Mar2025 | ₹-41 Cr | Negative | |
| Mar2024 | ₹93 Cr | Positive | |
| Mar2023 | ₹-29 Cr | Negative | |
| Mar2022 | ₹27 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹86,051.2 Cr | -0% | 13.8% | 93.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,786.0 Cr | 0.8% | 7.3% | 15.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,590.0 Cr | 1.9% | 8.2% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,658.0 Cr | 0.6% | 12.6% | 43.9% | Stock Analytics | |
| CIPLA | ₹115,728.0 Cr | 0.2% | 6.3% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,708.0 Cr | -1.8% | -3.5% | -3.4% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0% |
13.8% |
93.4% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses